UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone

European urology, 2014-01, Vol.65 (1), p.30-36

2014

Volltextzugriff (PDF)

NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers

BMC cancer, 2024-03, Vol.24 (1), p.346-346, Article 346

2024

Volltextzugriff (PDF)

Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells

PloS one, 2014-06, Vol.9 (6), p.e98566-e98566

2014

Volltextzugriff (PDF)

Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection

PloS one, 2013, Vol.8 (5), p.e65189

2013

Volltextzugriff (PDF)

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer

PloS one, 2011-09, Vol.6 (9), p.e25341

2011

Volltextzugriff (PDF)

JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells

BMC cancer, 2012-03, Vol.12 (1), p.130-130, Article 130

2012

Volltextzugriff (PDF)

IκB Kinases Modulate the Activity of the Androgen Receptor in Prostate Carcinoma Cell Lines

Neoplasia (New York, N.Y.), 2012-03, Vol.14 (3), p.178-IN6

2012

Volltextzugriff (PDF)

Detecting predictive androgen receptor modifications in circulating prostate cancer cells

Oncotarget, 2019-06, Vol.10 (41), p.4213-4223

2019

Volltextzugriff (PDF)

Detection of AR-V7 in primary prostate cancer

Cancer treatment and research communications, 2021, Vol.28, p.100230-100230, Article 100230

2021

Volltextzugriff (PDF)

Antibody selection influences the detection of AR-V7 in primary prostate cancer

Cancer treatment and research communications, 2020, Vol.24, p.100186-100186, Article 100186

2020

Volltextzugriff (PDF)

Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells

International journal of molecular sciences, 2012-09, Vol.13 (9), p.11530-11542

2012

Volltextzugriff (PDF)

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer

Oncotarget, 2015-11, Vol.6 (34), p.35542-35555

2015

Volltextzugriff (PDF)

Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines

Oncogene, 2004-04, Vol.23 (20), p.3541-3549

2004

Volltextzugriff (PDF)

Corpulence is the crucial factor: Association of testosterone and/or obesity with prostate cancer stage

International journal of urology, 2014-10, Vol.21 (10), p.980-986

2014

Volltextzugriff (PDF)

Inhibition of Glycogen Synthase Kinase-3 in Androgen-Responsive Prostate Cancer Cell Lines: Are GSK Inhibitors Therapeutically Useful?

Neoplasia (New York, N.Y.), 2008-06, Vol.10 (6), p.624,IN3-633,IN3

2008

Volltextzugriff (PDF)

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer

Journal of cancer research and clinical oncology, 2024-02, Vol.150 (2), p.76-76, Article 76

2024

Volltextzugriff (PDF)

Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2024-04, Vol.132 (4), p.256-266

2024

Volltextzugriff (PDF)

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression

Molecular oncology, 2024-09

2024

Volltextzugriff (PDF)

Androgen receptor aberrations in the era of abiraterone and enzalutamide

World Journal of Urology, 2016-03, Vol.34 (3), p.297-303

2016

Volltextzugriff (PDF)

Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7

World journal of urology, 2016-05, Vol.34 (5), p.633-639

2016

Volltextzugriff (PDF)

C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer

The Journal of steroid biochemistry and molecular biology, 2017-02, Vol.166, p.38-44

2017

Volltextzugriff (PDF)

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer

Cancers, 2022-09, Vol.14 (18), p.4441

2022

Volltextzugriff (PDF)

NF-κB signaling in prostate cancer: A promising therapeutic target?

World journal of urology, 2012-06, Vol.30 (3), p.303-310

2012

Volltextzugriff (PDF)

Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1–3

European urology, 2017-04, Vol.71 (4), p.e105-e106

2017

Volltextzugriff (PDF)

Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer

Expert opinion on pharmacotherapy, 2017-01, Vol.18 (1), p.105-113

2017

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(80)
Buchkapitel
(1)

Sprache

Englisch
(81)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

World Journal Of Urology
(12)
European Urology
(9)
The Prostate
(9)
Plos One
(7)
Cancer Research
(5)
Neoplasia
(4)
Bmc Cancer
(3)
The Journal Of Urology
(3)
Cancer Treatment And Research Communications
(2)
International Journal Of Cancer
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone

NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers

Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cells

Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer

JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells

IκB Kinases Modulate the Activity of the Androgen Receptor in Prostate Carcinoma Cell Lines

Detecting predictive androgen receptor modifications in circulating prostate cancer cells

Detection of AR-V7 in primary prostate cancer

Antibody selection influences the detection of AR-V7 in primary prostate cancer

Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer

Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines

Corpulence is the crucial factor: Association of testosterone and/or obesity with prostate cancer stage

Inhibition of Glycogen Synthase Kinase-3 in Androgen-Responsive Prostate Cancer Cell Lines: Are GSK Inhibitors Therapeutically Useful?

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer

Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression

Androgen receptor aberrations in the era of abiraterone and enzalutamide

Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7

C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer

NF-κB signaling in prostate cancer: A promising therapeutic target?

Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1–3

Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer

Suchergebnisse filtern